<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">pgen</journal-id><journal-title>PLoS Genetics</journal-title><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1371/journal.pgen.0030105</article-id><article-id pub-id-type="publisher-id">06-PLGE-RA-0433R2</article-id><article-id pub-id-type="sici">plge-03-06-18</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics</subject><subject>Genetics and Genomics</subject><subject>Genetics and Genomics</subject><subject>Molecular Biology</subject></subj-group><subj-group subj-group-type="System Taxonomy"><subject>Saccharomyces</subject></subj-group></article-categories><title-group><article-title>Sensitivity of Yeast Strains with Long G-Tails to Levels of Telomere-Bound Telomerase</article-title><alt-title alt-title-type="running-head">Yeast Pif1p and Telomere Maintenance</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Vega</surname><given-names>Leticia R</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref ref-type="fn" rid="n104">&#x000a4;</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Phillips</surname><given-names>Jane A</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Thornton</surname><given-names>Brian R</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Benanti</surname><given-names>Jennifer A</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Onigbanjo</surname><given-names>Mutiat T</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Toczyski</surname><given-names>David P</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Zakian</surname><given-names>Virginia A</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref ref-type="corresp" rid="cor1">&#x0002a;</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Department of Molecular Biology, Princeton University, Princeton, New Jersey, United States of America </aff><aff id="aff2"><label>2</label> Cancer Research Institute, Department of Biochemistry and Biophysics, University of California, San Francisco California, United States of America </aff><contrib-group><contrib contrib-type="editor"><name><surname>Snyder</surname><given-names>Michael</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">Yale University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; To whom correspondence should be addressed. E-mail: <email>vzakian&#x00040;princeton.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>22</day><month>6</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>22</day><month>6</month><year>2007</year></pub-date><volume>3</volume><issue>6</issue><elocation-id>e105</elocation-id><history><date date-type="received"><day>9</day><month>10</month><year>2006</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2007</year></date></history><copyright-statement><bold>Copyright:</bold> &#x000a9; 2007 Vega et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><p>The <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> Pif1p helicase is a negative regulator of telomere length that acts by removing telomerase from chromosome ends. The catalytic subunit of yeast telomerase, Est2p, is telomere associated throughout most of the cell cycle, with peaks of association in both G1 phase (when telomerase is not active) and late S/G2 phase (when telomerase is active). The G1 association of Est2p requires a specific interaction between Ku and telomerase RNA. In mutants lacking this interaction, telomeres were longer in the absence of Pif1p than in the presence of wild-type <italic>PIF1,</italic> indicating that endogenous Pif1p inhibits the active S/G2 form of telomerase. Pif1p abundance was cell cycle regulated, low in G1 and early S phase and peaking late in the cell cycle. Low Pif1p abundance in G1 phase was anaphase-promoting complex dependent. Thus, endogenous Pif1p is unlikely to act on G1 bound Est2p. Overexpression of Pif1p from a non-cell cycle-regulated promoter dramatically reduced viability in five strains with impaired end protection <italic>(cdc13&#x02013;1</italic>, <italic>yku80</italic>&#x00394;, <italic>yku70</italic>&#x00394;, <italic>yku80&#x02013;1</italic>, and <italic>yku80&#x02013;4),</italic> all of which have longer single-strand G-tails than wild-type cells. This reduced viability was suppressed by deleting the <italic>EXO1</italic> gene, which encodes a nuclease that acts at compromised telomeres, suggesting that the removal of telomerase by Pif1p exposed telomeres to further C-strand degradation. Consistent with this interpretation, depletion of Pif1p, which increases the amount of telomere-bound telomerase, suppressed the temperature sensitivity of <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells. Furthermore, eliminating the pathway that recruits Est2p to telomeres in G1 phase in a <italic>cdc13&#x02013;1</italic> strain also reduced viability. These data suggest that wild-type levels of telomere-bound telomerase are critical for the viability of strains whose telomeres are already susceptible to degradation.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><sec id="st1"><title/><p>Telomeres, the ends of linear chromosomes, are essential for chromosome stability. Telomerase is the enzyme that is responsible for lengthening telomeres in most organisms, including humans. One mechanism of survival for many human cancers is increased expression of telomerase. In baker's yeast, telomerase acts only late in the cell cycle, even though the catalytic subunit of telomerase is telomere bound throughout most of the cell cycle. Pif1p is a yeast helicase that limits telomerase by removing it from DNA ends. We demonstrate that Pif1p abundance is cell cycle regulated with its highest expression at the same time when telomerase acts. Consistent with this expression pattern, Pif1p is able to remove the active form of telomerase from DNA ends. Reducing the amount of telomere-bound telomerase either by Pif1p overexpression or by mutation in strains with defective telomere end protection causes death. Moreover, reducing Pif1p levels in the same end protection mutants improves their growth. These experiments suggest that compared to wild-type cells, strains with defective end protection require more telomere-bound telomerase for the proper replication or proper protection of their chromosome ends.</p></sec></abstract><counts><page-count count="11"/></counts><custom-meta-wrap><custom-meta><meta-name>citation</meta-name><meta-value>Vega LR, Phillips JA, Thornton BR, Benanti JA, Onigbanjo MT, et al. (2007) Sensitivity of yeast strains with long G-tails to levels of telomere-bound telomerase. PLoS Genet 3(6): e105. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pgen.0030105">10.1371/journal.pgen.0030105</ext-link></meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Telomeres, the physical ends of linear chromosomes, are required for the complete replication and stable maintenance of eukaryotic chromosomes. They are comprised of stretches of repeated C/G-rich DNA with the G-rich strand extended to form a 3&#x02032; single-stranded tail (G-tail). In <italic>S. cerevisiae,</italic> chromosomes end in ~300 base pairs of C<sub>1&#x02013;3</sub>A/TG<sub>1&#x02013;3</sub> DNA. Although yeast telomeres bear short G-tails throughout most of the cell cycle &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b001">1</xref>&#x0005d;, long G-tails occur transiently in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b002">2</xref>&#x0005d;.</p><p>As in many organisms, yeast telomeric DNA is assembled into a non-nucleosomal chromatin structure called the telosome &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b003">3</xref>&#x0005d;. The essential protein Cdc13p is a telosome component that binds the single-stranded G-tail and is required to protect telomeric DNA from degradation (reviewed in &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b004">4</xref>,<xref ref-type="bibr" rid="pgen-0030105-b005">5</xref>&#x0005d;). Likewise, the heterodimeric Ku complex, encoded by <italic>YKU70</italic> and <italic>YKU80,</italic> is telomere associated &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b006">6</xref>&#x0005d; and helps protect telomeres from degradation and from inappropriate recombination &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b007">7</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b009">9</xref>&#x0005d;. When yeast cells are limited for Cdc13p or for the Ku complex, they have long single-stranded G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b006">6</xref>,<xref ref-type="bibr" rid="pgen-0030105-b010">10</xref>&#x0005d;. Disruption of the 5&#x02032; to 3&#x02032; exonuclease <italic>EXO1</italic> in <italic>yku80</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> strains suppresses the formation of these long G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b011">11</xref>&#x0005d;. Thus, Cdc13p and Ku are both required for telomere integrity. In their absence, telomeres are more prone to C-strand degradation mediated by Exo1p and perhaps other nucleases.</p><p>From yeasts to humans, telomeric DNA is replicated by a specialized reverse transcriptase called telomerase. In <italic>S. cerevisiae, EST2</italic> encodes the catalytic subunit of telomerase, <italic>TLC1</italic> encodes the templating RNA, and <italic>EST1</italic> encodes a telomerase subunit that functions in recruitment and perhaps activation of telomerase (reviewed in &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b004">4</xref>&#x0005d;). Yeast telomerase action is cell cycle regulated: it is able to lengthen telomeres only in the late S/G2 phase even though telomerase activity can be detected by in vitro assays in extracts prepared from cells at other times in the cell cycle &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b012">12</xref>,<xref ref-type="bibr" rid="pgen-0030105-b013">13</xref>&#x0005d;. However, Est2p is telomere associated throughout most of the cell cycle &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d;, including G1 and early S phase when telomerase is not active &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b012">12</xref>,<xref ref-type="bibr" rid="pgen-0030105-b013">13</xref>&#x0005d;. The telomere binding of Est2p in G1 phase requires a specific interaction between <italic>TLC1</italic> RNA and Yku80p, an interaction that is eliminated in both <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku80</italic>-<italic>135i</italic> mutants &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b015">15</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d;. Since telomeres are short but stable in <italic>yku70</italic>&#x00394;, <italic>yku80</italic>&#x00394;, <italic>tlc1</italic>&#x00394;<italic>48,</italic> and <italic>yku80-135i</italic> cells, the G1 recruitment of Est2p contributes to, but is not essential for, telomere length maintenance. The Ku-TLC1 interaction also contributes to the formation of new telomeres at double-strand breaks &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d;.</p><p>There is a second peak of Est2p association in late S/G2 phase that occurs at the same time in the cell cycle when Cdc13p binding increases, Est1p binding occurs &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d;, and telomerase acts &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b012">12</xref>,<xref ref-type="bibr" rid="pgen-0030105-b013">13</xref>&#x0005d;. This late S/G2 peak of Est2p binding is lost in the telomerase defective <italic>cdc13&#x02013;2</italic> strain &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d; as well as in several other telomerase deficient strains, such as an <italic>est1</italic>&#x00394; strain (K.M. Daumer, J.B. Boul&#x000e9;, A. Chan, T.S. Fisher, and V.A. Zakian, unpublished data). In contrast, in <italic>tlc</italic>&#x00394;<italic>48, yku80</italic>-<italic>135i,</italic> and <italic>yku</italic>&#x00394; cells, Est2p and Est1p are telomere associated in late S/G2 phase, albeit at reduced levels relative to wild-type cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;. Thus, there are two pathways that recruit Est2p to telomeres. Although both pathways contribute to telomere maintenance, the late S/G2 peak is necessary and sufficient for telomerase-mediated lengthening. The mechanism by which the G1 phase Est2p binding contributes to telomere maintenance is not known.</p><p>The Pif1p helicase, a member of a helicase family conserved from yeasts to humans (reviewed in &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b018">18</xref>&#x0005d;), was first identified because of its role in the maintenance of yeast mitochondrial DNA &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b019">19</xref>&#x0005d;. However, cells also express a nuclear form of Pif1p that is a negative regulator of telomerase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. The telomeric role of Pif1p was discovered because of its strong inhibition of telomerase-mediated telomere addition to double-strand breaks &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>&#x0005d;. This inhibition contributes to genome stability as gross chromosomal rearrangements such as translocations and deletions are elevated ~1,000-fold in <italic>pif1</italic>&#x00394; cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b023">23</xref>&#x0005d;. Pif1p also affects the lengths of existing telomeres: reduced Pif1p causes telomere lengthening, while overexpressed Pif1p results in modest telomere shortening &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>,<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;. The effects of Pif1p on telomere addition and lengthening of existing telomeres require both telomerase and the helicase activity of Pif1p, indicating that Pif1p acts catalytically to inhibit telomerase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>,<xref ref-type="bibr" rid="pgen-0030105-b023">23</xref>&#x0005d;. Indeed, in vitro Pif1p reduces the processivity of telomerase and releases active telomerase from telomeric oligonucleotides &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. In vivo, overexpression of Pif1p reduces Est2p and Est1p association with telomeres, whereas depletion of Pif1p increases the levels of telomere-bound Est1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;, the telomerase subunit that is present on the telomere only when telomerase is active &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d;. Thus, Pif1p helicase activity limits telomerase action both in vivo and in vitro by displacing active telomerase from DNA ends.</p><p>In addition to reducing the levels of telomere-bound telomerase, overexpression of Pif1p results in increased telomeric association of Cdc13p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. Since increased Cdc13p binding occurs when telomeres have long G-tails, as in a <italic>yku</italic>&#x00394; strain &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d; or in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d;, these data suggest that unscheduled Pif1p-mediated removal of telomerase impairs the structural integrity of the telomere. Here we show that the abundance of nuclear Pif1p is cell cycle regulated with peak abundance late in the cell cycle when telomerase is active. Overexpression of Pif1p reduced the viability of <italic>yku</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells. This reduced viability was suppressed by mutations in <italic>EXO1,</italic> suggesting that the decreased viability was due to an exacerbation of the reduced end protection that occurs in these mutants upon removal of telomerase from telomeres that are already deficient in end protection. When the <italic>tlc1</italic>&#x00394;<italic>48</italic> or <italic>yku80-135i</italic> mutations were used to eliminate the G1 phase pathway for telomerase recruitment in <italic>cdc13&#x02013;1</italic> cells, the temperature-sensitive phenotype of this strain worsened. Limiting expression of nuclear Pif1p to late in the cell cycle may enhance the protective role of yeast telomerase by allowing enzymatically inactive telomerase to remain telomere associated throughout much of the cell cycle.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>Pif1p Expression Is Cell Cycle Regulated</title><p>To determine if Pif1p levels vary during the cell cycle, wild-type cells were arrested in late G1 phase with alpha factor and released synchronously into the cell cycle. Cell cycle progression was monitored by fluorescence-activated cell sorting (FACS) (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>A). Whole-cell protein extracts were prepared from samples taken throughout the cell cycle and analyzed by SDS-PAGE and western blotting using anti-Pif1p antibodies (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B). As previously demonstrated &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;, there are two major forms of Pif1p in cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, lane 3). The larger form, which is localized to nuclei, is the only form in cells carrying the <italic>pif1-m1</italic> allele &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>,<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d; (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, lane 2). The smaller form, which is generated by proteolysis during its import into mitochondria, is present in <italic>pif1-m2</italic> cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, lane 1). A minor species of somewhat slower mobility, which may be the uncleaved precursor of the mature mitochondrial form, is often visible in <italic>pif1-m2</italic> and <italic>PIF1</italic> (but not <italic>pif1-m1</italic>) cells (see also &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b024">24</xref>&#x0005d;).</p><p>In wild-type cells, both the nuclear (Nuc) and mitochondrial (MT) forms of Pif1p were present in asynchronous cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, ASY WT). However, the nuclear form was present in very low amounts in extracts from late G1 phase cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, 0- and 15-min time points) but increased in abundance as cells progressed through the cell cycle (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B, time points 30&#x02013;90 min). This cell cycle regulated pattern was confirmed by examining Pif1p abundance in <italic>pif1-m1</italic> cells, which express only the nuclear form of Pif1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>,<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;. Pif1p-m1 was barely detectable at 0 and 15 min but increased in abundance as cells progressed through S phase (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>C, <italic>pif1-m1</italic>). Mitochondrial Pif1p was also less abundant in G1 and early S phase than later in the cell cycle, but not to the same extent as Pif1p-m1 (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>C, <italic>pif1-m2</italic>). Quantitation of the gels in <xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>C indicates that the relative abundance of nuclear to mitochondrial Pif1p was low (0.2) in G1/early S phase and high late in the cell cycle (~3).</p></sec><sec id="s2b"><title>Steady State Levels of Nuclear Pif1p Are higher in Strains Lacking the Anaphase-Promoting Complex</title><p>Protein levels for mitochondrial Pif1p were higher than for nuclear Pif1p in late G1 phase cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>B and <xref ref-type="fig" rid="pgen-0030105-g001">1</xref>C, 0- and 15-min time points). This difference suggested that the compartmentalization of Pif1p into the mitochondria may protect it from degradation. Since the anaphase-promoting complex (APC) is active from anaphase through late G1 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b025">25</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b027">27</xref>&#x0005d;, we considered that nuclear Pif1p might be targeted for destruction by the APC. To test this possibility, we examined Pif1p levels in APC<sup>&#x0002b;</sup> and <italic>apc</italic>&#x00394; strains (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>D). Although the yeast APC is essential, its essential functions can be bypassed by deleting two of its targets <italic>(PDS1</italic> and <italic>CLB5)</italic> and overexpressing the Clb/CDK inhibitor, Sic1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b028">28</xref>&#x0005d;. We compared the levels of Pif1p in extracts from G1 cells obtained by elutriation and from cycling cells in both APC<sup>&#x0002b;</sup> and in <italic>apc</italic>&#x00394; strains by western blot analysis using anti-Pif1p antibodies. As a control, levels of Clb2p were also assayed (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>D). As expected, Clb2p was detected in extracts from G1 phase <italic>apc</italic>&#x00394; but not from G1 phase APC<sup>&#x0002b;</sup> cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>D, lanes 2 and 4). In the same extracts, the pattern of expression for nuclear Pif1p was similar to that of Clb2p; Pif1p was present in G1 phase cells in the <italic>apc</italic>&#x00394; but not in the APC<sup>&#x0002b;</sup> strain. In contrast, mitochondrial Pif1p was detectable in both G1 phase and asynchronous cells from both strains (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>D, lanes 2&#x02013;5). Furthermore, nuclear Pif1p was stabilized in alpha-factor arrested <italic>cdc23&#x02013;1</italic> cells at semipermissive temperatures (L.R. Vega and V.A. Zakian, unpublished data). As Cdc23p is an essential subunit of the APC &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b029">29</xref>,<xref ref-type="bibr" rid="pgen-0030105-b030">30</xref>&#x0005d;, these results also indicate that the abundance of nuclear Pif1p is APC dependent.</p><p>We also examined the stability of Pif1p in asynchronous APC<sup>&#x0002b;</sup> and <italic>apc</italic>&#x00394; cells after treatment with cycloheximide for various lengths of time (<xref ref-type="supplementary-material" rid="pgen-0030105-sg001">Figure S1</xref>). In the presence or absence of cycloheximide, the steady state levels of Pif1p were higher in <italic>apc</italic>&#x00394; than in APC<sup>&#x0002b;</sup> cells. Similar results were seen with the known APC target Clb2p but not for Cdc28p, a protein that is not turned over by the APC. Furthermore, during cycloheximide treatment, there was a modest, but reproducible increase in the half-life of Pif1p in <italic>apc</italic>&#x00394; versus APC<sup>&#x0002b;</sup> cells. Taken together, these experiments indicate that Pif1p levels are APC dependent.</p></sec><sec id="s2c"><title>Pif1p Acts on Late S/G2 Phase Telomerase</title><p>The reduced telomere association of Est2p seen upon Pif1p overexpression &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d; could be due to Pif1p affecting Est2p association with telomeres in G1 phase, late S/G2 phase, or both. The G1 telomere association of Est2p requires a specific interaction between the heterodimeric Ku complex and TLC1 RNA that is eliminated in <italic>yku70</italic>&#x00394;, <italic>tlc1</italic>&#x00394;<italic>48,</italic> or <italic>yku80-135i</italic> strains &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>,<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d;. To determine if Pif1p affects the late S/G2 phase activity of telomerase, we examined telomere length in <italic>pif1</italic>&#x00394; strains that also lacked G1 bound telomerase. If Pif1p acts on late S/G2 phase telomerase, we anticipate that telomeres will be longer in the double mutant strains than in the single mutant cells.</p><p>Diploids heterozygous for <italic>pif1</italic>&#x00394; and either <italic>tlc1</italic>&#x00394;<italic>48, yku80-135i</italic>, or <italic>yku70</italic>&#x00394; were sporulated and dissected. Single and double mutants were identified and assayed for telomere length by Southern blot analysis (<xref ref-type="fig" rid="pgen-0030105-g002">Figure 2</xref>). As expected, <italic>pif1</italic>&#x00394; spore clones (<xref ref-type="fig" rid="pgen-0030105-g002">Figure 2</xref>; lanes labeled 2) had longer telomeres than wild type (lanes 1), while the <italic>tlc1</italic>&#x00394;<italic>48</italic> (lanes 4), <italic>yku80-135i</italic> (lanes 6), and <italic>yku70</italic>&#x00394; (lanes 8) strains had short telomeres. In each case, the <italic>pif1</italic>&#x00394; double mutants had longer telomeres than the corresponding single mutants. For example, telomeres were longer in <italic>pif1</italic>&#x00394; <italic>yku80-135i</italic> cells (lanes 5) than in <italic>yku80-135i</italic> cells (lanes 6). Thus, endogenous Pif1p must be able to act on Est2p that is recruited to the telomere in late S/G2 phase since <italic>tlc1</italic>&#x00394;<italic>48</italic>, <italic>yku80-135i,</italic> and <italic>yku70</italic>&#x00394; cells lack G1 bound telomerase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;. However, Pif1p may also be able to remove Est2p that is telomere bound at other times in the cell cycle since the <italic>PIF1</italic> deletion had a smaller effect on telomere length in the <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku70</italic>&#x00394; backgrounds (but not in <italic>yku80-135i</italic> cells) than in wild-type cells.</p><p>There are no known separation-of-function alleles of <italic>TLC1</italic>, <italic>YKU,</italic> or other genes that eliminate telomerase binding in late S/G2 while retaining the ability to maintain telomeres by telomerase. Thus, it is not possible to do an experiment comparable to that in <xref ref-type="fig" rid="pgen-0030105-g002">Figure 2</xref> to determine if Pif1p removes Est2p from telomeres in G1 phase. However, since levels of nuclear Pif1p were low in G1 phase cells (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>), endogenous Pif1p likely acts primarily on the active telomerase that is telomere associated in late S/G2 phase.</p></sec><sec id="s2d"><title>Pif1p Overexpression Is Lethal in Strains Lacking Ku70p</title><p>Overexpression of Pif1p results in higher levels of telomere-bound Cdc13p, suggesting that Pif1p overexpressing cells have longer or more prolonged G-tails than wild-type cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. These data led us to consider that end protection might be compromised in Pif1p overexpressing cells due to the unscheduled removal of telomerase from chromosome ends. If this model is correct, overexpression of Pif1p from the non-cell cycle-regulated <italic>GAL1</italic> promoter might compromise the growth of strains such as <italic>yku</italic>&#x00394; that already have defects in end protection &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b007">7</xref>,<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b031">31</xref>&#x0005d;.</p><p>To test this possibility, wild-type and <italic>yku70</italic>&#x00394; strains were transformed with an empty plasmid or the same plasmid containing wild-type <italic>PIF1</italic> or the catalytically inactive <italic>pif1</italic>-<italic>K264A</italic> allele. Both the wild-type and the inactive <italic>pif1</italic>-<italic>K264A</italic> alleles were expressed under the control of the galactose inducible <italic>GAL1</italic> promoter &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. The viability of the strains after galactose induction at 30 &#x000b0;C was monitored by plating aliquots of the galactose grown culture back to glucose-containing plates (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>). Overexpression of Pif1p in wild-type cells conferred a very modest loss of viability (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>, squares). In contrast, overexpression of Pif1p in <italic>yku70</italic>&#x00394; cells resulted in a dramatic loss of viability (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>, large circles). This lethality required the helicase activity of Pif1p, since the viability of <italic>yku70</italic>&#x00394; (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>, small circles) and wild-type cells (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>, triangles) was unaffected by overexpressing the helicase inactive Pif1p-<italic>K264A</italic>. However, overexpression of Pif1p-<italic>K264A</italic> did result in slow growth, as reflected in reduced colony size in both wild-type and <italic>yku70</italic>&#x00394; cells (see <xref ref-type="fig" rid="pgen-0030105-g004">Figures 4</xref> and <xref ref-type="fig" rid="pgen-0030105-g005">5</xref>). Overexpression of wild-type Pif1p also caused lethality in <italic>yku80</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>B). Therefore, both subunits of the heterodimeric Ku complex are required for viability when wild-type Pif1p is overexpressed. While this paper was being prepared for publication, another group reported that Pif1p overexpression causes poor growth in <italic>yku70</italic>&#x00394; and <italic>yku80</italic>&#x00394; cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b032">32</xref>&#x0005d;.</p></sec><sec id="s2e"><title>Excess Pif1p Is Lethal only in Strains with Long G-Tails</title><p>In addition to its role at telomeres, Ku is also required for nonhomologous end-joining (NHEJ) (reviewed in &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b033">33</xref>&#x0005d;). To determine if the lethal effects of Pif1p overexpression in <italic>yku</italic>&#x00394; cells are related to the role of Ku in NHEJ, we overexpressed Pif1p in a <italic>lig4</italic>&#x00394; strain (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>C). <italic>LIG4</italic> encodes a ligase that is required for NHEJ but that does not affect telomeres &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b034">34</xref>,<xref ref-type="bibr" rid="pgen-0030105-b035">35</xref>&#x0005d;. As Pif1p overexpression did not reduce viability of <italic>lig4</italic>&#x00394; cells (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>C), its effects on viability of <italic>yku</italic>&#x00394; cells must be independent of NHEJ.</p><p>Another possibility is that overexpression of Pif1p, which results in modest telomere shortening &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;,would be lethal in any strain that has short telomeres. The ATM paralog Tel1p is a checkpoint kinase in <named-content content-type="genus-species">S. cerevisiae</named-content> that has a major role in telomere maintenance. Telomeres in <italic>tel1</italic>&#x00394; cells are very short but stable &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b036">36</xref>&#x0005d; with normal length G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b037">37</xref>&#x0005d; and wild-type levels of Cdc13p binding &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b038">38</xref>&#x0005d;. However, Est2p and Est1p telomere binding is markedly reduced in <italic>tel1</italic>&#x00394; cells, especially in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b038">38</xref>&#x0005d;. If Pif1p overexpression results in lethality in any strain with short telomeres, then overexpression of Pif1p should cause lethality in <italic>tel1</italic>&#x00394; cells. Contrary to this expectation, Pif1p overexpression did not reduce viability in <italic>tel1</italic>&#x00394; cells, although it did reduce growth rate (as it did in wild-type cells) (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>D).</p><p>If the lethality of <italic>yku</italic>&#x00394; strains that overexpress Pif1p results from the synergistic effects of reduced telomere end protection and reduced levels of telomere-associated telomerase, then overexpression of Pif1p might not affect viability in a strain that already lacks G1 phase telomerase but has normal end protection. The <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku80-135i</italic> mutations eliminate interaction between Yku80p and <italic>TLC1</italic> telomerase RNA &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>,<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d;, and these strains have no Est2p at telomeres in G1 phase and reduced telomere-associated Est2p and Est1p in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;. However, both strains have wild-type levels of Cdc13p and Ku telomere binding &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;, and both have wild-type or near wild-type length G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b015">15</xref>,<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>,<xref ref-type="bibr" rid="pgen-0030105-b039">39</xref>&#x0005d;. Overexpression of Pif1p was not lethal in either <italic>tlc1</italic>&#x00394;<italic>48</italic> (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>A) or <italic>yku80-135i</italic> (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>B) cells. In contrast, overexpression of Pif1p resulted in reduced viability of <italic>yku80&#x02013;1</italic> and <italic>yku80&#x02013;4</italic> cells (<xref ref-type="fig" rid="pgen-0030105-g004">Fig 4</xref>E), two mutants that have longer G-tails than wild-type cells and partial defects in end protection &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b039">39</xref>&#x0005d;.</p></sec><sec id="s2f"><title>Overexpression of Pif1p Results in Reduced Viability of <italic>cdc13&#x02013;1</italic> Strains at Permissive Temperatures</title><p>Of the strains examined, Pif1p overexpression reduced viability only in <italic>yku</italic> mutants that have longer G-tails. To determine if Pif1p overexpression is lethal in other strains with long G-tails, we examined the effects of Pif1p overexpression in <italic>cdc13&#x02013;1</italic> cells. Cells carrying the temperature sensitive <italic>cdc13&#x02013;1</italic> allele die at the restrictive temperature due to accumulation of single-stranded telomeric DNA but are viable at 23 &#x000b0;C &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b010">10</xref>&#x0005d;. A <italic>cdc13&#x02013;1</italic> strain was transformed with an empty plasmid or the same plasmid containing <italic>GAL</italic>-<italic>PIF1</italic> or <italic>GAL</italic>-<italic>pif1</italic>-<italic>K264A,</italic> plated to glucose or to galactose plates and incubated at 23 &#x000b0;C to monitor growth. As seen previously, wild-type cells were viable but slow growing when Pif1p was overexpressed (<xref ref-type="fig" rid="pgen-0030105-g005">Figure 5</xref>). However, overexpression of wild-type Pif1p (but not Pif1p-K264A) resulted in lethality of <italic>cdc13&#x02013;1</italic> cells at the normally permissive temperature of 23 &#x000b0;C. As expected, all of the strains had wild-type growth rates when grown on glucose medium at 23 &#x000b0;C (<xref ref-type="fig" rid="pgen-0030105-g005">Figure 5</xref>, right panel).</p></sec><sec id="s2g"><title>Deletion of <italic>EXO1</italic> Restores Viability to <italic>yku70</italic>&#x00394; Cells Overexpressing Pif1p and Partially Restores Viability to <italic>cdc13&#x02013;1</italic> Cells Overexpressing Pif1p</title><p>A <italic>yku70</italic>&#x00394; or <italic>yku80</italic>&#x00394; strain is viable at 30 &#x000b0;C but is unable to form colonies at 37 &#x000b0;C &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b040">40</xref>,<xref ref-type="bibr" rid="pgen-0030105-b041">41</xref>&#x0005d;. This temperature sensitivity is likely due to telomere defects as it can be suppressed by overexpression of telomerase subunits &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b042">42</xref>&#x0005d;, by amplification of subtelomeric repeats &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b043">43</xref>&#x0005d;, or by deletion of <italic>EXO1</italic> &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b044">44</xref>&#x0005d;. Deletion of <italic>EXO1</italic> also suppresses the temperature sensitivity of <italic>cdc13&#x02013;1</italic> cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b044">44</xref>&#x0005d;. We reasoned that removal of telomerase from telomeres in Pif1p overexpressing cells may allow nucleases such as Exo1p increased access to telomeric DNA. To test this model, we examined the effects of Pif1p overexpression in <italic>yku70</italic>&#x00394; or <italic>cdc13&#x02013;1</italic> cells that were also deleted for <italic>EXO1</italic>. If the model is correct, loss of Exo1p should relieve the lethality associated with excess Pif1p in these backgrounds.</p><p>Diploids heterozygous for <italic>EXO1</italic> and <italic>YKU70</italic> deletions were sporulated and dissected. Tetratype tetrad spores were transformed with an empty plasmid or with <italic>GAL</italic>-<italic>PIF1.</italic> We determined the ability of the various strains to form colonies on galactose and glucose plates at 30 &#x000b0;C. As predicted by the model, <italic>exo1</italic>&#x00394; <italic>yku70</italic>&#x00394; cells overexpressing Pif1p formed colonies on galactose plates (<xref ref-type="fig" rid="pgen-0030105-g006">Figure 6</xref>A, left panel). Thus, the loss of viability seen in <italic>yku70</italic>&#x00394; strains upon Pif1p overexpression requires the activity of Exo1p. Likewise, deletion of <italic>EXO1</italic> was able to partially restore growth to <italic>cdc13&#x02013;1</italic> cells overexpressing Pif1p (<xref ref-type="fig" rid="pgen-0030105-g006">Figure 6</xref>B, left panel). The fact that the rescue was not complete in the <italic>cdc13&#x02013;1</italic> background may reflect the fact that an as yet undiscovered nuclease acts in concert with Exo1p to generate telomeric single-stranded DNA in <italic>cdc13&#x02013;1</italic> cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b044">44</xref>&#x0005d;. The suppression of the inviability in Pif1p overexpressing <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells by <italic>EXO1</italic> deletion argues that the loss of viability is due to defects in telomere structure.</p></sec><sec id="s2h"><title>Loss of Pif1p Results in Partial Suppression of the Temperature Sensitivity of <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> Strains</title><p>Overexpression of Pif1p results in shortened telomeres and less telomere-bound telomerase, while Pif1p depletion results in long telomeres and more telomere-bound Est1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. Here we show that Pif1p overexpression caused lethality in strains that have long G-tails (<xref ref-type="fig" rid="pgen-0030105-g003">Figures 3</xref>&#x02013;<xref ref-type="fig" rid="pgen-0030105-g005">5</xref>). If overexpression of Pif1p in <italic>yku</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells leads to inviability by exacerbating the reduced end protection in these strains, then depleting cells of Pif1p might relieve the temperature sensitivity of <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells.</p><p>To test this possibility, we introduced the <italic>pif1-m2</italic> allele into <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells. A <italic>pif1-m2</italic> strain expresses mitochondrial but not nuclear Pif1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>,<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;. We used <italic>pif1-m2</italic> since <italic>pif1</italic>&#x00394; strains exhibit a petite phenotype that would impair our ability to monitor cell growth &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>&#x0005d;. Heterozygous diploids were sporulated and dissected. Tetratype tetrads were identified, spotted onto rich medium, and incubated at various temperatures to assay growth. As expected, <italic>yku70</italic>&#x00394; cells showed robust growth at 30 &#x000b0;C (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>A, left) and poor growth at 37 &#x000b0;C (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>A, right). The wild-type and <italic>pif1-m2</italic> control strains grew well at both temperatures. The double mutant <italic>yku70</italic>&#x00394; <italic>pif1-m2</italic> cells also grew well at both temperatures (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>A). Likewise, <italic>cdc13&#x02013;1 pif1-m2</italic> cells grew well at 28.2 &#x000b0;C (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>B, center), while <italic>cdc13&#x02013;1</italic> cells did not grow at 28.2 &#x000b0;C (center panel). (As this paper was being prepared for publication, another group identified <italic>pif1</italic>&#x00394; in a genome-wide screen for mutations that partially suppress the temperature sensitivity lethality of <italic>cdc13&#x02013;1</italic> cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b045">45</xref>&#x0005d;). This suppression of temperature sensitivity was not complete as <italic>cdc13&#x02013;1 pif1-m2</italic> cells did not grow at 30 &#x000b0;C (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>B, right). Thus, depleting <italic>yku70</italic>&#x00394; or <italic>cdc13&#x02013;1</italic> cells of nuclear Pif1p improved their ability to grow at high temperatures.</p></sec><sec id="s2i"><title>Disruption of the Ku-TLC1 RNA Interaction Exacerbates the Temperature Sensitivity of <italic>cdc13&#x02013;1</italic> Strains</title><p>To test our model that reduced levels of telomere-bound telomerase compromise viability in strains defective for telomere end protection, we examined the effects of eliminating the Ku/TLC1 RNA interaction using either the <italic>tlc1</italic>&#x00394;<italic>48</italic> or <italic>yku80-135i</italic> allele in a <italic>cdc13&#x02013;1</italic> strain. In both <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku80-135i</italic> cells, the telomere association &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d; and end-protection activity &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d; of Ku are not compromised, but the recruitment of Est2p to telomeres is lost in G1 phase and reduced in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;. If the G1 pathway for recruiting Est2p to telomeres contributes to end protection, the <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku80-135i</italic> alleles should exacerbate the temperature sensitivity of <italic>cdc13&#x02013;1</italic> cells. We constructed <italic>cdc13&#x02013;1 tlc1</italic>&#x00394;<italic>48</italic> and <italic>cdc13&#x02013;1 yku80</italic>-<italic>135i</italic> double mutant strains and compared their growth at various temperatures to both wild-type and single mutant strains. Both double mutants were more temperature sensitive than the <italic>cdc13&#x02013;1</italic> single mutant strain (<xref ref-type="fig" rid="pgen-0030105-g008">Figure 8</xref>). Thus, reducing telomere association of telomerase using <italic>tlc1</italic>&#x00394;<italic>48, yku80-135i</italic>, or Pif1p overexpression reduces the viability of <italic>cdc13&#x02013;1</italic> cells.</p></sec></sec><sec id="s3"><title>Discussion</title><p>We show that the nuclear form of the Pif1p helicase, which removes telomerase from DNA ends in vivo and in vitro &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;, is a cell cycle-regulated protein. This regulation is achieved both by regulated accumulation of its mRNA &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b046">46</xref>&#x0005d; (a result also confirmed in our work, unpublished data) and by APC dependent regulation of Pif1p (<xref ref-type="fig" rid="pgen-0030105-g001">Figures 1</xref> and S1). As a result, the nuclear form of Pif1p peaked in abundance at about the same time in the cell cycle that telomerase lengthens telomeres (<xref ref-type="fig" rid="pgen-0030105-g001">Figure 1</xref>) &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b012">12</xref>&#x0005d;. Restricting the expression of nuclear Pif1p to late in the cell cycle may facilitate the G1 phase telomere association of Est2p.</p><p>The cell cycle pattern of Pif1p abundance is consistent with telomere length analyses that indicate that endogenous Pif1p removes telomerase from late S/G2 phase telomeres (<xref ref-type="fig" rid="pgen-0030105-g002">Figure 2</xref>). Deleting Pif1p resulted in longer telomeres in three strains, <italic>yku80-135i, tlc1</italic>&#x00394;<italic>48,</italic> and <italic>yku70</italic>&#x00394;, in which telomerase is telomere associated only in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d;. Thus, endogenous Pif1p must be able to act on the catalytically active form of telomerase that exists only transiently, late in the cell cycle. This conclusion is also supported by our previous finding that deleting <italic>PIF1</italic> results in more telomere-associated Est1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;, which is telomere associated only in late S/G2 phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>&#x0005d;. Endogenous Pif1p may also act on telomerase that is recruited to the telomere in G1 phase via a Ku-TLC1RNA interaction, since telomere elongation in the absence of Pif1p was not as great in <italic>tlc1</italic>&#x00394;48 or <italic>yku70</italic>&#x00394; cells as it was in wild-type cells (<xref ref-type="fig" rid="pgen-0030105-g002">Figure 2</xref>). In addition, during the formation of new telomeres, Pif1p almost surely acts on Ku-recruited telomerase since the large increase in de novo telomere addition seen in <italic>pif1</italic>&#x00394; cells is virtually eliminated in the absence of Ku &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b023">23</xref>&#x0005d;.</p><p>The pattern of cell cycle-regulated abundance of nuclear Pif1p is similar to that observed for Est1p. In cells synchronized with alpha factor, Est1p is present in low amounts in late G1 phase and peaks in abundance in late S phase &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>,<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>,<xref ref-type="bibr" rid="pgen-0030105-b047">47</xref>&#x0005d;. This pattern is achieved by both regulated mRNA accumulation &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b046">46</xref>,<xref ref-type="bibr" rid="pgen-0030105-b048">48</xref>&#x0005d; and proteasome dependent Est1p degradation &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b047">47</xref>&#x0005d;. The pattern and mechanism of cell cycle-regulated abundance of yeast Pif1p is also remarkably similar to that seen for the human PIF1-like protein, hPIF1 &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b049">49</xref>&#x0005d;. Like yeast Pif1p, hPIF1 abundance is controlled at both the mRNA and protein levels, and hPIF appears to be a direct target of the APC. In addition, hPIF is associated in vivo with TERT, the catalytic subunit of human telomerase. Likewise, in <named-content content-type="genus-species">S. cerevisiae</named-content>, mutations in the finger domain of Est2p reduce the sensitivity of telomere length to Pif1p, suggesting that the two yeast proteins also interact in vivo &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b050">50</xref>&#x0005d;.</p><p>Overexpression of baker's yeast Pif1p from the non-cell cycle-regulated <italic>GAL1</italic> promoter results in reduced Est2p and Est1p at telomeres and elevated Cdc13p binding &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b022">22</xref>&#x0005d;. High Cdc13p binding is seen in strains with long G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b014">14</xref>,<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>&#x0005d; and low Cdc13p binding is seen in a strain with short G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b037">37</xref>,<xref ref-type="bibr" rid="pgen-0030105-b038">38</xref>&#x0005d;. Thus, elevated Cdc13p binding in Pif1p overexpressing cells suggests that Pif1p action exposes telomeres to degradation, which generates long G-tails. Excess Pif1p affected growth rate but had very little or no effect on viability of wild-type, <italic>tel1</italic>&#x00394;, <italic>tlc1</italic>&#x00394;<italic>48,</italic> or <italic>yku80-135i</italic> cells (<xref ref-type="fig" rid="pgen-0030105-g004">Figure 4</xref>). All of these mutant strains have short telomeres but normal, or near normal, length G-tails &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>,<xref ref-type="bibr" rid="pgen-0030105-b037">37</xref>,<xref ref-type="bibr" rid="pgen-0030105-b039">39</xref>&#x0005d;. In contrast, Pif1p overexpression reduced viability in five strains <italic>(yku70</italic>&#x00394;, <italic>yku80</italic>&#x00394;, <italic>cdc13&#x02013;1, yku80&#x02013;1,</italic> and <italic>yku80&#x02013;4)</italic> (<xref ref-type="fig" rid="pgen-0030105-g003">Figures 3</xref>&#x02013;<xref ref-type="fig" rid="pgen-0030105-g005">5</xref>), in which G-tails are longer and end protection is reduced compared to wild-type cells &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b006">6</xref>,<xref ref-type="bibr" rid="pgen-0030105-b010">10</xref>,<xref ref-type="bibr" rid="pgen-0030105-b039">39</xref>&#x0005d;. Since this loss of viability required the enzymatic activity of Pif1p (<xref ref-type="fig" rid="pgen-0030105-g003">Figures 3</xref>&#x02013;<xref ref-type="fig" rid="pgen-0030105-g005">5</xref>, <italic>pif1-K264A</italic>), the deleterious effects of Pif1p overexpression are unlikely due to the titration of a structural protein(s) away from telomeres. We also reduced the levels of telomere-associated Est2p by a method that did not involve changing Pif1p levels. We introduced the <italic>tcl1</italic>&#x00394;<italic>48</italic> or the <italic>yku80-135i</italic> allele into the <italic>cdc13&#x02013;1</italic> strain (<xref ref-type="fig" rid="pgen-0030105-g008">Figure 8</xref>). Both of these alleles eliminate the interaction between TLC1 RNA and Ku, an interaction that is required to bring Est2p to the telomere in G1 phase and for wild-type levels of telomerase in late S/G2 phase but does not affect Ku or Cdc13p telomere binding &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b016">16</xref>,<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>&#x0005d;. Both the <italic>cdc13&#x02013;1 tcl1</italic>&#x00394;<italic>48</italic> cells and the <italic>cdc13&#x02013;1 yku80-135i</italic> cells were more temperature sensitive than <italic>cdc13&#x02013;1</italic> cells (<xref ref-type="fig" rid="pgen-0030105-g008">Figure 8</xref>). Thus, removing Est2p from telomeres in G1 phase and/or reducing telomerase levels in late S/G2 phase by mutation or by Pif1p overexpression is deleterious to telomere function but only in strains where reduced telomere end protection leads to long G-tails.</p><p>A possible explanation for the effects of Pif1p overexpression and of the <italic>tlc1</italic>&#x00394;<italic>48</italic> and <italic>yku80-135i</italic> alleles on the viability of <italic>cdc13&#x02013;1</italic> and <italic>yku</italic>&#x00394; cells is that combining either of these mutations with any condition that causes telomere shortening exacerbates their inherent defects in telomere capping. However, deleting <italic>TEL1</italic> results in very short telomeres &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b036">36</xref>&#x0005d;, yet <italic>tel1</italic>&#x00394; <italic>cdc13&#x02013;1</italic> and <italic>tel1</italic>&#x00394; <italic>yku</italic>&#x00394; cells are viable &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b009">9</xref>&#x0005d;. In addition, when <italic>TEL1</italic> is deleted in a <italic>cdc13&#x02013;1</italic> or <italic>yku</italic>&#x00394; strain, compared to the single mutant, the capping defect is either unchanged (<italic>cdc13&#x02013;1 tel1</italic>&#x00394;) or modestly increased (<italic>yku</italic>&#x00394; <italic>tel1</italic>&#x00394;). We conclude that reducing the levels of telomere-associated Est2p is lethal in strains that have a defect in telomere capping that is manifest by increased access to nucleases and hence longer G-tails. This interpretation is supported by the finding that deleting <italic>EXO1</italic>, a 5&#x02032; to 3&#x02032; exonuclease that acts at telomeres &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b008">8</xref>,<xref ref-type="bibr" rid="pgen-0030105-b011">11</xref>&#x0005d;, suppressed the lethal effects of Pif1p overexpression in <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> cells (<xref ref-type="fig" rid="pgen-0030105-g006">Figure 6</xref>). Even endogenous levels of Pif1p must further decrease the already compromised telomere function of <italic>cdc13&#x02013;1</italic> and <italic>yku70</italic>&#x00394; cells since depleting nuclear Pif1p in these backgrounds improved viability in both strains (<xref ref-type="fig" rid="pgen-0030105-g007">Figure 7</xref>).</p><p>There are two general models that can explain why reduced Est2p telomere binding impairs viability and increased Est2p improves viability in strains with long G-tails. The first model suggests that when G-tails are long, reducing the amount of telomere-bound Est2p makes it harder to lengthen telomeres. For example, when G-tails are long and telomerase is limiting, it may be difficult to position Est2p at the very end of the G-tail, which is essential for it to extend the 3&#x02032; terminus. This model is supported by the finding that the number of telomerase complexes in yeast is low, perhaps as low or lower than the number of telomeres per cell &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b051">51</xref>&#x0005d;. Indeed, Est2p is haplo-insufficient in diploid <italic>yku80</italic>&#x00394; cells (J.A. Phillips, L.R. Vega, and V.A. Zakian, unpublished data). The second model suggests that the pathway that recruits Est2p to telomeres in G1 phase and that is required for wild-type levels of telomere-associated telomerase in late S/G2 phase contributes to telomere end protection. In this model, the role of Est2p in end protection would be dispensable except in strains in which end protection is already reduced. A structural role for telomerase in end protection is consistent with results in other organisms. For example, in the yeast <italic>Candida albicans,</italic> deleting telomerase subunits results in very rapid telomere shortening, much faster than that expected from incomplete replication alone &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b052">52</xref>&#x0005d;, and ectopic expression of enzymatically compromised TERT in cultured human cells can extend their replicative lifespan without increasing telomere length &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b053">53</xref>&#x02013;<xref ref-type="bibr" rid="pgen-0030105-b055">55</xref>&#x0005d;.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Strains and growth conditions.</title><p>All experiments were carried out in the YPH499 background (<italic>MAT</italic>a <italic>ura3&#x02013;52 lys2&#x02013;801 ade2&#x02013;101 trp1-</italic>&#x00394;<italic>63 his1-</italic>&#x00394;<italic>200 leu2-</italic>&#x00394;<italic>1</italic> &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b056">56</xref>&#x0005d;) except the <italic>pif1-m1</italic> and <italic>pif1-m2</italic> synchronies and the APC experiments, which were carried out in the W303 background (<italic>MAT</italic>a <italic>leu2&#x02013;3,112 trp1&#x02013;1 can1&#x02013;100 ura3&#x02013;1 ade2&#x02013;1 his3&#x02013;11,15</italic> &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b057">57</xref>&#x0005d;). For Pif1p overexpression experiments, strains were transformed with either the pSH380 plasmid (empty vector control, a pRS315-derived <italic>CEN</italic> plasmid &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b056">56</xref>,<xref ref-type="bibr" rid="pgen-0030105-b058">58</xref>&#x0005d;) or pVS45, which is pSH380 containing the nuclear form of Pif1p under the control of the <italic>GAL1</italic> promoter, or with pGPKA, which is the same as pVS45 except that the <italic>PIF1</italic> gene contains the K264A mutation in the Walker A box, which inactivates the ATPase/helicase activity of Pif1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b021">21</xref>&#x0005d;<italic>.</italic> The <italic>pif1</italic>&#x00394;, <italic>pif1-m1</italic>, <italic>pif1-m2</italic> &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b020">20</xref>&#x0005d;, and <italic>lig4</italic>&#x00394; &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b059">59</xref>&#x0005d; strains were as described. The <italic>exo1</italic>::<italic>URA3</italic> deletion was created using pMPY 3xHA as described (see <xref ref-type="table" rid="pgen-0030105-t001">Table 1</xref> for sequence of primers) &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b060">60</xref>&#x0005d;. After PCR amplification, the <italic>EXO1</italic> deletion fragment was gel purified and used to transform YPH499 and YPH500 (these two strains are isogenic except at the <italic>MAT</italic> locus). Transformants were selected on complete synthetic media lacking uracil, and integration was verified by Southern blot analysis. Deletion of <italic>YKU80</italic> was done in a similar manner (see <xref ref-type="table" rid="pgen-0030105-t001">Table 1</xref> for primers). The <italic>cdc13&#x02013;1</italic> mutation &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b010">10</xref>&#x0005d; was introduced by multiple backcrosses into the YPH499 background by A. Taggart. <italic>yku70</italic>&#x00394;::<italic>HIS3</italic> &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b061">61</xref>&#x0005d; or <italic>cdc13&#x02013;1</italic> cells were mated to <italic>exo1</italic>&#x00394;::<italic>URA3</italic> cells. Cells were sporulated, tetrads were dissected, and tetratype tetrads were identified by the segregation of appropriate genetic markers. Each spore clone was transformed independently with pSH380, pVS45, and pGPKA, and assayed for growth on plates lacking leucine containing either 3&#x00025; galactose or 2&#x00025; glucose. Two individual tetratype tetrads were assayed for growth. Cells bearing the <italic>pif1-m2</italic> allele were crossed to either <italic>yku70</italic>&#x00394;::<italic>HIS3</italic> or to <italic>cdc13&#x02013;1</italic> strains at 23 &#x000b0;C, diploids were selected and restreaked two to five times prior to sporulation to equilibrate telomere length. <italic>tlc1</italic>&#x00394;<italic>48, yku80-135i</italic> (generously provided by D. Gottschling)<italic>, yku80&#x02013;1,</italic> and <italic>yku80&#x02013;4</italic> (generously provided by A. Bertuch and V. Lundblad) alleles have been described &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b017">17</xref>,<xref ref-type="bibr" rid="pgen-0030105-b039">39</xref>,<xref ref-type="bibr" rid="pgen-0030105-b062">62</xref>&#x0005d;. Construction of <italic>apc</italic>&#x00394; <italic>(pds1</italic>&#x00394;, <italic>clb5</italic>&#x00394;, <italic>SIC1<sup>10X</sup></italic>, <italic>apc2</italic>&#x00394;, <italic>apc1</italic>&#x00394;, <italic>cdc20</italic>&#x00394;, and <italic>cdh1</italic>&#x00394;<italic>)</italic> and APC<sup>&#x0002b;</sup> strains (<italic>pds1</italic>&#x00394;, <italic>clb5</italic>&#x00394;, and <italic>SIC1<sup>10X</sup> APC</italic><sup>&#x0002b;</sup><italic>)</italic> has been previously described &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b028">28</xref>&#x0005d;.</p></sec><sec id="s4b"><title>Synchrony experiment.</title><p>Wild-type, <italic>pif1-m1,</italic> and <italic>pif1-m2</italic> strains were grown overnight in YEPD media at 30 &#x000b0;C to log phase. The cultures were diluted to OD<sub>660</sub> of 0.15 and arrested with 9 &#x003bc;g/ml alpha factor at 23 &#x000b0;C for 4 h. At T &#x0003d; 0, cultures were washed and resuspended in YEPD containing 20 &#x003bc;g/ml pronase. At the indicated time points, cells were harvested for protein, RNA, and FACS analysis by adding NaN<sub>3</sub>/EDTA. Equivalent cell numbers were harvested at each time point. For western blot analysis, protein was harvested by TCA treatment &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b063">63</xref>&#x0005d;, and protein yields were quantitated by Bradford assays (Bio-Rad, <ext-link ext-link-type="uri" xlink:href="http://www.bio-rad.com">http://www.bio-rad.com</ext-link>). We subjected 25 &#x003bc;g of total protein to SDS-PAGE analysis on 10&#x00025; gels. After transfer onto nitrocellulose membranes, blots were blocked in 5&#x00025; NFM/TBST 0.5&#x00025; Tween 20 overnight and then probed for 3 h with antibodies raised against the amino terminus of Pif1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b064">64</xref>&#x0005d;. Protein extracts for APC experiments were prepared as described in &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b028">28</xref>&#x0005d;. For FACS analysis, cells were analyzed in a FACScan single laser fixed-alignment benchtop analyzer with an emission at 488 nm. A 530/30 band-pass filter was used to collect emissions in front of the detector.</p></sec><sec id="s4c"><title>Pif1p half-life assay.</title><p>APC<sup>&#x0002b;</sup> and <italic>apc</italic>&#x00394; strains were grown to log phase at 23 &#x000b0;C and treated with 50 &#x003bc;g/ml cycloheximide. Equivalent OD of cells were collected for western blot, and samples fixed in 70&#x00025; ethanol for flow cytometery at increasing time points. Protein extracts were made by first boiling cells in preheated SDS sample buffer (50 mM Tris &#x0005b;pH 7.5&#x0005d;, 5 mM EDTA, 5&#x00025; SDS, 10&#x00025; glycerol, 0.5&#x00025; &#x003b2;-mercaptoethanol, bromophenol blue, 1 &#x003bc;g/ml leupeptin, 1&#x003bc;g/ml bestatin, 1 mM benzamidine, 1 &#x003bc;g/ml pepstatin A, 17 &#x003bc;g/ml PMSF, 5 mM sodium fluoride, 80 mM &#x003b2;-glycerophosphate, and 1 mM sodium orthovanadate) for 5 min. Following boiling, glass beads were added and samples were subjected to bead beating for 3 min in a Mini BeadBeater (Biospec, <ext-link ext-link-type="uri" xlink:href="http://www.biospec.com">http://www.biospec.com</ext-link>). Extracts were subjected to SDS-PAGE on 9&#x00025; gels and analyzed by western blot with antibodies against Pif1p &#x0005b;<xref ref-type="bibr" rid="pgen-0030105-b064">64</xref>&#x0005d;, Clb2p, and Cdc28p (Santa Cruz Biotechnology, <ext-link ext-link-type="uri" xlink:href="http://www.scbt.com">http://www.scbt.com</ext-link>). For cell cycle analysis, fixed cells were sonicated, treated with 0.25 mg/ml RNaseA for 1 h at 50 &#x000b0;C, followed by digestion with 0.125 mg/ml Proteinase K for 1 h at 50 &#x000b0;C, and labeling with 1 &#x003bc;M Sytox Green (Invitrogen, <ext-link ext-link-type="uri" xlink:href="http://www.invitrogen.com">http://www.invitrogen.com</ext-link>). Data were collected using a FACS Calibur (Becton Dickinson, <ext-link ext-link-type="uri" xlink:href="http://www.bd.com">http://www.bd.com</ext-link>) and analyzed with FlowJo (Tree Star, <ext-link ext-link-type="uri" xlink:href="http://www.treestar.com">http://www.treestar.com</ext-link>) software.</p></sec><sec id="s4d"><title>Cell viability assays.</title><p>To determine viability of liquid grown cells (<xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref>), wild-type or <italic>yku70</italic>&#x00394; cells containing the indicated plasmids were grown overnight at 30 &#x000b0;C in defined medium lacking leucine (to select for the plasmid) containing 3&#x00025; raffinose. At time zero, galactose was added to a final concentration of 3&#x00025; w/v to induce protein expression. At the indicated time points, viability was monitored by plating a known number of cells (as determined by counting cells with a hemacytometer) onto selective plates containing glucose that were incubated at 30 &#x000b0;C. For the plating experiments in <xref ref-type="fig" rid="pgen-0030105-g004">Figures 4</xref>&#x02013;<xref ref-type="fig" rid="pgen-0030105-g008">8</xref>, cells were grown in selective liquid media containing glucose overnight at 30 &#x000b0;C or at the indicated temperature. Cultures were serially diluted in water and spotted onto selective glucose plates and galactose plates and incubated at 30 &#x000b0;C or at the indicated temperature to monitor growth.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pgen-0030105-sg001"><label>Figure S1</label><caption><title>Pif1p Is Stabilized in <italic>apc</italic>&#x00394; Cells</title><p>APC<sup>&#x0002b;</sup> and <italic>apc</italic>&#x00394; cells were treated with cycloheximide (chx) for the indicated number of minutes (min chx), and levels of Pif1p and the established APC target Clb2p were analyzed by western blot. Short and long exposures of the blots are shown to allow comparison between the two cell types. Cdc28p is shown as a loading control. Cell cycle position was analyzed by flow cytometry at each time point, demonstrating that the cell cycle position was similar in APC<sup>&#x0002b;</sup> and <italic>apc</italic>&#x00394; strains.</p><p>(752 KB AI).</p></caption><media xlink:href="pgen.0030105.sg001.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank A. Amon, A. Bertuch, D. Gottschling, and V. Lundblad for strains and J.B. Boule, M. Mateyak, M. Sabourin, F. Solomon, C. Tuzon, and C. Webb for comments on the manuscript. </p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>APC</term><def><p>anaphase-promoting complex</p></def></def-item><def-item><term>FACS</term><def><p>fluorescence-activated cell sorting</p></def></def-item><def-item><term>NHEJ</term><def><p>nonhomologous end-joining</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pgen-0030105-b001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larrivee</surname><given-names>M</given-names></name><name><surname>LeBel</surname><given-names>C</given-names></name><name><surname>Wellinger</surname><given-names>RJ</given-names></name></person-group><year>2004</year><article-title>The generation of proper constitutive G-tails on yeast telomeres is dependent on the MRX complex</article-title><source>Genes Dev</source><volume>18</volume><fpage>1391</fpage><lpage>1396</lpage><pub-id pub-id-type="pmid">15198981</pub-id></citation></ref><ref id="pgen-0030105-b002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wellinger</surname><given-names>RJ</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>1993</year><article-title><italic>Saccharomyces</italic> telomeres acquire single-strand TG<sub>1&#x02013;3</sub> tails late in S phase</article-title><source>Cell</source><volume>72</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">8422682</pub-id></citation></ref><ref id="pgen-0030105-b003"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>JH</given-names></name><name><surname>Gottschling</surname><given-names>DE</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>1992</year><article-title><italic>Saccharomyces</italic> telomeres assume a non-nucleosomal chromatin structure</article-title><source>Genes Dev</source><volume>6</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">1737616</pub-id></citation></ref><ref id="pgen-0030105-b004"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vega</surname><given-names>L</given-names></name><name><surname>Mateyak</surname><given-names>M</given-names></name><name><surname>Zakian</surname><given-names>V</given-names></name></person-group><year>2003</year><article-title>Getting to the end: Telomerase access in yeast and humans</article-title><source>Nat Rev Mol Cell Biol</source><volume>4</volume><fpage>948</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">14685173</pub-id></citation></ref><ref id="pgen-0030105-b005"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smogorzewska</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>T</given-names></name></person-group><year>2004</year><article-title>Regulation of telomerase by telomeric proteins</article-title><source>Annu Rev Biochem</source><volume>73</volume><fpage>177</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">15189140</pub-id></citation></ref><ref id="pgen-0030105-b006"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gravel</surname><given-names>S</given-names></name><name><surname>Larrivee</surname><given-names>M</given-names></name><name><surname>Labrecque</surname><given-names>P</given-names></name><name><surname>Wellinger</surname><given-names>RJ</given-names></name></person-group><year>1998</year><article-title>Yeast Ku as a regulator of chromosomal DNA end structure</article-title><source>Science</source><volume>280</volume><fpage>741</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">9563951</pub-id></citation></ref><ref id="pgen-0030105-b007"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polotnianka</surname><given-names>RM</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lustig</surname><given-names>AJ</given-names></name></person-group><year>1998</year><article-title>The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities</article-title><source>Curr Biol</source><volume>8</volume><fpage>831</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">9663392</pub-id></citation></ref><ref id="pgen-0030105-b008"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maringele</surname><given-names>L</given-names></name><name><surname>Lydall</surname><given-names>D</given-names></name></person-group><year>2002</year><article-title>EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70Delta mutants</article-title><source>Genes Dev</source><volume>16</volume><fpage>1919</fpage><lpage>1933</lpage><pub-id pub-id-type="pmid">12154123</pub-id></citation></ref><ref id="pgen-0030105-b009"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DuBois</surname><given-names>ML</given-names></name><name><surname>Haimberger</surname><given-names>ZW</given-names></name><name><surname>McIntosh</surname><given-names>MW</given-names></name><name><surname>Gottschling</surname><given-names>DE</given-names></name></person-group><year>2002</year><article-title>A quantitative assay for telomere protection in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Genetics</source><volume>161</volume><fpage>995</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">12136006</pub-id></citation></ref><ref id="pgen-0030105-b010"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garvik</surname><given-names>B</given-names></name><name><surname>Carson</surname><given-names>M</given-names></name><name><surname>Hartwell</surname><given-names>L</given-names></name></person-group><year>1995</year><article-title>Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the <italic>RAD9</italic> checkpoint</article-title><source>Mol Cell Biol</source><volume>15</volume><fpage>6128</fpage><lpage>6138</lpage><pub-id pub-id-type="pmid">7565765</pub-id></citation></ref><ref id="pgen-0030105-b011"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertuch</surname><given-names>AA</given-names></name><name><surname>Lundblad</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>EXO1 contributes to telomere maintenance in both telomerase-proficient and telomerase-deficient <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Genetics</source><volume>166</volume><fpage>1651</fpage><lpage>1659</lpage><pub-id pub-id-type="pmid">15126387</pub-id></citation></ref><ref id="pgen-0030105-b012"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marcand</surname><given-names>S</given-names></name><name><surname>Brevet</surname><given-names>V</given-names></name><name><surname>Mann</surname><given-names>C</given-names></name><name><surname>Gilson</surname><given-names>E</given-names></name></person-group><year>2000</year><article-title>Cell cycle restriction of telomere elongation</article-title><source>Curr Biol</source><volume>10</volume><fpage>487</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">10801419</pub-id></citation></ref><ref id="pgen-0030105-b013"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diede</surname><given-names>SJ</given-names></name><name><surname>Gottschling</surname><given-names>DE</given-names></name></person-group><year>1999</year><article-title>Telomerase-mediated telomere addition <italic>in vivo</italic> requires DNA primase and DNA polymerases alpha and delta</article-title><source>Cell</source><volume>99</volume><fpage>723</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">10619426</pub-id></citation></ref><ref id="pgen-0030105-b014"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname><given-names>AKP</given-names></name><name><surname>Teng</surname><given-names>S-C</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2002</year><article-title>Est1p as a cell cycle-regulated activator of telomere-bound telomerase</article-title><source>Science</source><volume>297</volume><fpage>1023</fpage><lpage>1026</lpage><pub-id pub-id-type="pmid">12169735</pub-id></citation></ref><ref id="pgen-0030105-b015"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>SE</given-names></name><name><surname>Stellwagen</surname><given-names>AE</given-names></name><name><surname>Diede</surname><given-names>SJ</given-names></name><name><surname>Singer</surname><given-names>MS</given-names></name><name><surname>Haimberger</surname><given-names>ZW</given-names></name><etal/></person-group><year>2001</year><article-title>The function of a stem-loop in telomerase RNA is linked to the DNA repair protein Ku</article-title><source>Nat Genet</source><volume>27</volume><fpage>64</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">11138000</pub-id></citation></ref><ref id="pgen-0030105-b016"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>T</given-names></name><name><surname>Taggart</surname><given-names>A</given-names></name><name><surname>Zakian</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>Cell cycle-dependent regulation of yeast telomerase by Ku</article-title><source>Nat Struct Mol Biol</source><volume>11</volume><fpage>1198</fpage><lpage>1205</lpage><pub-id pub-id-type="pmid">15531893</pub-id></citation></ref><ref id="pgen-0030105-b017"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stellwagen</surname><given-names>AE</given-names></name><name><surname>Haimberger</surname><given-names>ZW</given-names></name><name><surname>Veatch</surname><given-names>JR</given-names></name><name><surname>Gottschling</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>Ku interacts with telomerase RNA to promote telomere addition at native and broken chromosome ends</article-title><source>Genes Dev</source><volume>17</volume><fpage>2384</fpage><lpage>2395</lpage><pub-id pub-id-type="pmid">12975323</pub-id></citation></ref><ref id="pgen-0030105-b018"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>JB</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2006</year><article-title>Roles of Pif1-like helicases in the maintenance of genomic stability</article-title><source>Nucl Acids Res</source><volume>34</volume><fpage>4147</fpage><lpage>4153</lpage><pub-id pub-id-type="pmid">16935874</pub-id></citation></ref><ref id="pgen-0030105-b019"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foury</surname><given-names>F</given-names></name><name><surname>Kolodynski</surname><given-names>J</given-names></name></person-group><year>1983</year><article-title>pif mutation blocks recombination between mitochondrial rho&#x0002b; and rho&#x02212; genomes having tandemly arrayed repeat units in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Proc Natl Acad Sci U S A</source><volume>80</volume><fpage>5345</fpage><lpage>5349</lpage><pub-id pub-id-type="pmid">6310571</pub-id></citation></ref><ref id="pgen-0030105-b020"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>VP</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>1994</year><article-title>The <italic>Saccharomyces PIF1</italic> DNA helicase inhibits telomere elongation and <italic>de novo</italic> telomere formation</article-title><source>Cell</source><volume>76</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">8287473</pub-id></citation></ref><ref id="pgen-0030105-b021"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J-Q</given-names></name><name><surname>Monson</surname><given-names>EM</given-names></name><name><surname>Teng</surname><given-names>S-C</given-names></name><name><surname>Schulz</surname><given-names>VP</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2000</year><article-title>The Pif1p helicase, a catalytic inhibitor of telomerase lengthening of yeast telomeres</article-title><source>Science</source><volume>289</volume><fpage>771</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">10926538</pub-id></citation></ref><ref id="pgen-0030105-b022"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boule</surname><given-names>J</given-names></name><name><surname>Vega</surname><given-names>L</given-names></name><name><surname>Zakian</surname><given-names>V</given-names></name></person-group><year>2005</year><article-title>The Yeast Pif1p helicase removes telomerase from DNA</article-title><source>Nature</source><volume>438</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16121131</pub-id></citation></ref><ref id="pgen-0030105-b023"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myung</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Kolodner</surname><given-names>RD</given-names></name></person-group><year>2001</year><article-title>Multiple pathways cooperate in the suppression of genome instability in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Nature</source><volume>411</volume><fpage>1073</fpage><lpage>1076</lpage><pub-id pub-id-type="pmid">11429610</pub-id></citation></ref><ref id="pgen-0030105-b024"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lahaye</surname><given-names>A</given-names></name><name><surname>Stahl</surname><given-names>H</given-names></name><name><surname>Thines-Sempoux</surname><given-names>D</given-names></name><name><surname>Foury</surname><given-names>F</given-names></name></person-group><year>1991</year><article-title>PIF1: A DNA helicase in yeast mitochondria</article-title><source>EMBO J</source><volume>10</volume><fpage>997</fpage><lpage>1007</lpage><pub-id pub-id-type="pmid">1849081</pub-id></citation></ref><ref id="pgen-0030105-b025"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amon</surname><given-names>A</given-names></name><name><surname>Irniger</surname><given-names>S</given-names></name><name><surname>Nasmyth</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>Closing the cell cycle circle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle</article-title><source>Cell</source><volume>77</volume><fpage>1037</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">8020094</pub-id></citation></ref><ref id="pgen-0030105-b026"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>RW</given-names></name><name><surname>Peters</surname><given-names>JM</given-names></name><name><surname>Tugendreich</surname><given-names>S</given-names></name><name><surname>Rolfe</surname><given-names>M</given-names></name><name><surname>Hieter</surname><given-names>P</given-names></name><etal/></person-group><year>1995</year><article-title>A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B</article-title><source>Cell</source><volume>81</volume><fpage>279</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">7736580</pub-id></citation></ref><ref id="pgen-0030105-b027"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudakin</surname><given-names>V</given-names></name><name><surname>Ganoth</surname><given-names>D</given-names></name><name><surname>Dahan</surname><given-names>A</given-names></name><name><surname>Heller</surname><given-names>H</given-names></name><name><surname>Hershko</surname><given-names>J</given-names></name><etal/></person-group><year>1995</year><article-title>The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis</article-title><source>Mol Biol Cell</source><volume>6</volume><fpage>185</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">7787245</pub-id></citation></ref><ref id="pgen-0030105-b028"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thornton</surname><given-names>BR</given-names></name><name><surname>Toczyski</surname><given-names>DP</given-names></name></person-group><year>2003</year><article-title>Securin and B-cyclin/CDK are the only essential targets of the APC</article-title><source>Nat Cell Biol</source><volume>5</volume><fpage>1090</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">14634663</pub-id></citation></ref><ref id="pgen-0030105-b029"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamb</surname><given-names>JR</given-names></name><name><surname>Michaud</surname><given-names>WA</given-names></name><name><surname>Sikorski</surname><given-names>RS</given-names></name><name><surname>Hieter</surname><given-names>PA</given-names></name></person-group><year>1994</year><article-title>Cdc16p, Cdc23p and Cdc27p form a complex essential for mitosis</article-title><source>EMBO J</source><volume>13</volume><fpage>4321</fpage><lpage>4328</lpage><pub-id pub-id-type="pmid">7925276</pub-id></citation></ref><ref id="pgen-0030105-b030"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Irniger</surname><given-names>S</given-names></name><name><surname>Piatti</surname><given-names>S</given-names></name><name><surname>Michaelis</surname><given-names>C</given-names></name><name><surname>Nasmyth</surname><given-names>K</given-names></name></person-group><year>1995</year><article-title>Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast</article-title><source>Cell</source><volume>81</volume><fpage>269</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">7736579</pub-id></citation></ref><ref id="pgen-0030105-b031"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nugent</surname><given-names>CI</given-names></name><name><surname>Bosco</surname><given-names>G</given-names></name><name><surname>Ross</surname><given-names>LO</given-names></name><name><surname>Evans</surname><given-names>SK</given-names></name><name><surname>Salinger</surname><given-names>AP</given-names></name><etal/></person-group><year>1998</year><article-title>Telomere maintenance is dependent on activities required for end repair of double-strand breaks</article-title><source>Curr Biol</source><volume>8</volume><fpage>657</fpage><lpage>660</lpage><pub-id pub-id-type="pmid">9635193</pub-id></citation></ref><ref id="pgen-0030105-b032"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Myung</surname><given-names>K</given-names></name></person-group><year>2006</year><article-title>Suppression of gross chromosomal rearrangements by yKu70-yKu80 heterodimer through DNA damage checkpoints</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>1816</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">16446442</pub-id></citation></ref><ref id="pgen-0030105-b033"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>TS</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2005</year><article-title>Ku: A multifunctional protein involved in telomere maintenance</article-title><source>DNA Rep (Amst)</source><volume>4</volume><fpage>1215</fpage><lpage>1226</lpage></citation></ref><ref id="pgen-0030105-b034"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>SH</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year>1997</year><article-title>Identification of <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> DNA ligase IV: Involvement in DNA double-strand break repair</article-title><source>EMBO J</source><volume>16</volume><fpage>4788</fpage><lpage>4795</lpage><pub-id pub-id-type="pmid">9303323</pub-id></citation></ref><ref id="pgen-0030105-b035"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schar</surname><given-names>P</given-names></name><name><surname>Herrmann</surname><given-names>G</given-names></name><name><surname>Daly</surname><given-names>G</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><year>1997</year><article-title>A newly identified DNA ligase of <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> involved in <italic>RAD52</italic>-independent repair of DNA double-strand breaks</article-title><source>Genes Dev</source><volume>11</volume><fpage>1912</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">9271115</pub-id></citation></ref><ref id="pgen-0030105-b036"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenwell</surname><given-names>PW</given-names></name><name><surname>Kronmal</surname><given-names>SL</given-names></name><name><surname>Porter</surname><given-names>SE</given-names></name><name><surname>Gassenhuber</surname><given-names>J</given-names></name><name><surname>Obermaier</surname><given-names>B</given-names></name><etal/></person-group><year>1995</year><article-title>TEL1, a gene involved in controlling telomere length in <italic>S. cerevisiae,</italic> is homologous to the human ataxia telangiectasia gene</article-title><source>Cell</source><volume>82</volume><fpage>823</fpage><lpage>829</lpage><pub-id pub-id-type="pmid">7671310</pub-id></citation></ref><ref id="pgen-0030105-b037"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Matsuura</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Late S phase-specific recruitment of Mre11 complex triggers hierarchical assembly of telomere replication proteins in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Mol Cell</source><volume>17</volume><fpage>573</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">15721260</pub-id></citation></ref><ref id="pgen-0030105-b038"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goudsouzian</surname><given-names>L</given-names></name><name><surname>Tuzon</surname><given-names>C</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2006</year><article-title><named-content content-type="genus-species">S. cerevisiae</named-content> Tel1p and Mre11p are required for normal levels of Est1p and Est2p telomere association</article-title><source>Mol Cell</source><volume>24</volume><fpage>603</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">17188035</pub-id></citation></ref><ref id="pgen-0030105-b039"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bertuch</surname><given-names>AA</given-names></name><name><surname>Lundblad</surname><given-names>V</given-names></name></person-group><year>2003</year><article-title>The Ku heterodimer performs separable activities at double-strand breaks and chromosome termini</article-title><source>Mol Cell Biol</source><volume>23</volume><fpage>8202</fpage><lpage>8215</lpage><pub-id pub-id-type="pmid">14585978</pub-id></citation></ref><ref id="pgen-0030105-b040"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feldmann</surname><given-names>H</given-names></name><name><surname>Winnacker</surname><given-names>EL</given-names></name></person-group><year>1993</year><article-title>A putative homologue of the human autoantigen Ku from <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>J Biol Chem</source><volume>268</volume><fpage>12895</fpage><lpage>12900</lpage><pub-id pub-id-type="pmid">8509423</pub-id></citation></ref><ref id="pgen-0030105-b041"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feldmann</surname><given-names>H</given-names></name><name><surname>Driller</surname><given-names>L</given-names></name><name><surname>Meier</surname><given-names>B</given-names></name><name><surname>Mages</surname><given-names>G</given-names></name><name><surname>Kellermann</surname><given-names>J</given-names></name><etal/></person-group><year>1996</year><article-title>HDF2, the second subunit of the Ku homologue from <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>J Biol Chem</source><volume>271</volume><fpage>27765</fpage><lpage>27769</lpage><pub-id pub-id-type="pmid">8910371</pub-id></citation></ref><ref id="pgen-0030105-b042"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teo</surname><given-names>SH</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><year>2001</year><article-title>Telomerase subunit overexpression suppresses telomere-specific checkpoint activation in the yeast <italic>yku80</italic> mutant</article-title><source>EMBO Rep</source><volume>2</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">11266360</pub-id></citation></ref><ref id="pgen-0030105-b043"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fellerhoff</surname><given-names>B</given-names></name><name><surname>Eckardt-Schupp</surname><given-names>F</given-names></name><name><surname>Friedl</surname><given-names>AA</given-names></name></person-group><year>2000</year><article-title>Subtelomeric repeat amplification is associated with growth at elevated temperature in <italic>yku70</italic> mutants of <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Genetics</source><volume>154</volume><fpage>1039</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">10757752</pub-id></citation></ref><ref id="pgen-0030105-b044"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zubko</surname><given-names>MK</given-names></name><name><surname>Guillard</surname><given-names>S</given-names></name><name><surname>Lydall</surname><given-names>D</given-names></name></person-group><year>2004</year><article-title>Exo1 and Rad24 differentially regulate generation of ssDNA at telomeres of <italic>Saccharomyces cerevisiae</italic> cdc13&#x02013;1 mutants</article-title><source>Genetics</source><volume>168</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">15454530</pub-id></citation></ref><ref id="pgen-0030105-b045"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Downey</surname><given-names>M</given-names></name><name><surname>Houlsworth</surname><given-names>R</given-names></name><name><surname>Maringele</surname><given-names>L</given-names></name><name><surname>Rollie</surname><given-names>A</given-names></name><name><surname>Brehme</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator</article-title><source>Cell</source><volume>124</volume><fpage>1155</fpage><lpage>1168</lpage><pub-id pub-id-type="pmid">16564010</pub-id></citation></ref><ref id="pgen-0030105-b046"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Iyer</surname><given-names>VR</given-names></name><name><surname>Anders</surname><given-names>K</given-names></name><etal/></person-group><year>1998</year><article-title>Comprehensive identification of cell cycle-regulated genes of the yeast <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> by microarray hybridization</article-title><source>Mol Biol Cell</source><volume>9</volume><fpage>3273</fpage><lpage>3297</lpage><pub-id pub-id-type="pmid">9843569</pub-id></citation></ref><ref id="pgen-0030105-b047"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Osterhage</surname><given-names>JL</given-names></name><name><surname>Talley</surname><given-names>JM</given-names></name><name><surname>Friedman</surname><given-names>KL</given-names></name></person-group><year>2006</year><article-title>Proteasome-dependent degradation of Est1p regulates the cell cycle-restricted assembly of telomerase in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Nat Struct Mol Biol</source><volume>13</volume><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">16862158</pub-id></citation></ref><ref id="pgen-0030105-b048"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larose</surname><given-names>S</given-names></name><name><surname>Laterreur</surname><given-names>N</given-names></name><name><surname>Ghazal</surname><given-names>G</given-names></name><name><surname>Gagnon</surname><given-names>J</given-names></name><name><surname>Wellinger</surname><given-names>RJ</given-names></name><etal/></person-group><year>2007</year><article-title>RNase III-dependent regulation of yeast telomerase</article-title><source>J Biol Chem</source><volume>282</volume><fpage>4373</fpage><lpage>4381</lpage><pub-id pub-id-type="pmid">17158880</pub-id></citation></ref><ref id="pgen-0030105-b049"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mateyak</surname><given-names>M</given-names></name><name><surname>Zakian</surname><given-names>V</given-names></name></person-group><year>2006</year><article-title>Human PIF helicase is cell cycle regulated and associates with telomerase</article-title><source>Cell Cycle</source><volume>23</volume><fpage>2796</fpage><lpage>2804</lpage><pub-id pub-id-type="pmid">17172855</pub-id></citation></ref><ref id="pgen-0030105-b050"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eugster</surname><given-names>A</given-names></name><name><surname>Lanzuolo</surname><given-names>C</given-names></name><name><surname>Bonneton</surname><given-names>M</given-names></name><name><surname>Luciano</surname><given-names>P</given-names></name><name><surname>Pollice</surname><given-names>A</given-names></name><etal/></person-group><year>2006</year><article-title>The finger subdomain of yeast telomerase cooperates with Pif1p to limit telomere elongation</article-title><source>Nat Struct Mol Biol</source><volume>13</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">16878131</pub-id></citation></ref><ref id="pgen-0030105-b051"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mozdy</surname><given-names>AD</given-names></name><name><surname>Cech</surname><given-names>TR</given-names></name></person-group><year>2006</year><article-title>Low abundance of telomerase in yeast: Implications for telomerase haploinsufficiency</article-title><source>RNA</source><volume>12</volume><fpage>1721</fpage><lpage>1737</lpage><pub-id pub-id-type="pmid">16894218</pub-id></citation></ref><ref id="pgen-0030105-b052"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Lue</surname><given-names>N</given-names></name></person-group><year>2003</year><article-title>Ever shorter telomere 1 (EST1)-dependent reverse transcription by <italic>Candida</italic> telomerase <italic>in vitro</italic>: Evidence in support of an activating function</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>5718</fpage><lpage>5723</lpage><pub-id pub-id-type="pmid">12716976</pub-id></citation></ref><ref id="pgen-0030105-b053"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Bishop</surname><given-names>JM</given-names></name><name><surname>Blackburn</surname><given-names>EH</given-names></name></person-group><year>1999</year><article-title>Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>3723</fpage><lpage>3728</lpage><pub-id pub-id-type="pmid">10097104</pub-id></citation></ref><ref id="pgen-0030105-b054"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Cherry</surname><given-names>AM</given-names></name><name><surname>Bangs</surname><given-names>CD</given-names></name><name><surname>Oei</surname><given-names>Y</given-names></name><etal/></person-group><year>1999</year><article-title>Human endothelial cell life extension by telomerase expression</article-title><source>J Biol Chem</source><volume>274</volume><fpage>26141</fpage><lpage>26148</lpage><pub-id pub-id-type="pmid">10473565</pub-id></citation></ref><ref id="pgen-0030105-b055"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>SA</given-names></name><name><surname>Hahn</surname><given-names>WC</given-names></name><name><surname>O'Connor</surname><given-names>BF</given-names></name><name><surname>Banner</surname><given-names>EN</given-names></name><name><surname>Lundberg</surname><given-names>AS</given-names></name><etal/></person-group><year>2002</year><article-title>Telomerase contributes to tumorigenesis by a telomere length-independent mechanism</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>12606</fpage><lpage>12611</lpage><pub-id pub-id-type="pmid">12193655</pub-id></citation></ref><ref id="pgen-0030105-b056"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sikorski</surname><given-names>RS</given-names></name><name><surname>Hieter</surname><given-names>P</given-names></name></person-group><year>1989</year><article-title>A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Genetics</source><volume>122</volume><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">2659436</pub-id></citation></ref><ref id="pgen-0030105-b057"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>BJ</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name></person-group><year>1989</year><article-title>Elevated recombination rates in transcriptionally active DNA</article-title><source>Cell</source><volume>56</volume><fpage>619</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">2645056</pub-id></citation></ref><ref id="pgen-0030105-b058"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>RW</given-names></name></person-group><year>1984</year><article-title>Sequences that regulate the divergent GAL1-GAL10 promoter in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Mol Cell Biol</source><volume>4</volume><fpage>1440</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">6092912</pub-id></citation></ref><ref id="pgen-0030105-b059"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>JZ</given-names></name><name><surname>Schnakenberg</surname><given-names>SL</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2004</year><article-title>The <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content> Rrm3p DNA helicase promotes genome integrity by preventing replication fork stalling: Viability of <italic>rrm3</italic> cells requires the intra S phase checkpoint and fork restart activities</article-title><source>Mol Cell Biol</source><volume>24</volume><fpage>3198</fpage><lpage>3212</lpage><pub-id pub-id-type="pmid">15060144</pub-id></citation></ref><ref id="pgen-0030105-b060"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>BL</given-names></name><name><surname>Seufert</surname><given-names>W</given-names></name><name><surname>Steiner</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>QH</given-names></name><name><surname>Futcher</surname><given-names>AB</given-names></name></person-group><year>1995</year><article-title>Use of polymerase chain reaction epitope tagging for protein tagging in <named-content content-type="genus-species">Saccharomyces cerevisiae</named-content></article-title><source>Yeast</source><volume>11</volume><fpage>1265</fpage><lpage>1274</lpage><pub-id pub-id-type="pmid">8553697</pub-id></citation></ref><ref id="pgen-0030105-b061"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tham</surname><given-names>WH</given-names></name><name><surname>Wyithe</surname><given-names>JS</given-names></name><name><surname>Ferrigno</surname><given-names>PK</given-names></name><name><surname>Silver</surname><given-names>PA</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2001</year><article-title>Localization of yeast telomeres to the nuclear periphery is separable from transcriptional repression and telomere stability functions</article-title><source>Mol Cell</source><volume>8</volume><fpage>189</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">11511372</pub-id></citation></ref><ref id="pgen-0030105-b062"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>CL</given-names></name><name><surname>Kruger</surname><given-names>W</given-names></name><name><surname>Herskowitz</surname><given-names>I</given-names></name></person-group><year>1991</year><article-title>A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1</article-title><source>Cell</source><volume>64</volume><fpage>1135</fpage><lpage>1143</lpage><pub-id pub-id-type="pmid">2004420</pub-id></citation></ref><ref id="pgen-0030105-b063"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Foiani</surname><given-names>M</given-names></name><name><surname>Liberi</surname><given-names>G</given-names></name><name><surname>Piatti</surname><given-names>S</given-names></name><name><surname>Plevani</surname><given-names>P</given-names></name></person-group><year>1999</year><article-title><named-content content-type="genus-species">Saccharomyces cerevisia</named-content>e as a model system to study DNA replication</article-title><comment>In:</comment><person-group person-group-type="editor"><name><surname>Cotterill</surname><given-names>S</given-names></name></person-group><source>Eukaryotic DNA replication a practical approach</source><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford University Press</publisher-name><fpage>185</fpage><lpage>200</lpage></citation></ref><ref id="pgen-0030105-b064"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ivessa</surname><given-names>AS</given-names></name><name><surname>Zhou</surname><given-names>J-Q</given-names></name><name><surname>Zakian</surname><given-names>VA</given-names></name></person-group><year>2000</year><article-title>The <italic>Saccharomyces</italic> Pif1p DNA helicase and the highly related Rrm3p have opposite effects on replication fork progression in ribosomal DNA</article-title><source>Cell</source><volume>100</volume><fpage>479</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">10693764</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="pgen-0030105-g001" position="float"><label>Figure 1</label><caption><title>Pif1p Abundance Is Cell Cycle Regulated and APC Dependent</title><p>(A and B) Wild-type cells were arrested in alpha factor at 24 &#x000b0;C and released into the cell cycle by the addition of pronase. At the indicated times, cells were harvested for FACS analysis to monitor DNA content (A) and by western blot analysis using anti-Pif1p antibodies to determine levels of nuclear (Nuc) and mitochondrial (MT) Pif1p and then with anti-gamma tubulin antibodies as a loading control (B). Pif1p abundance was also determined in asynchronous (ASY) <italic>PIF1</italic> (WT), <italic>pif1-m2</italic> (which express only mitochondrial Pif1p; -<italic>m2</italic>), and <italic>pif1-m1</italic> (which express only nuclear Pif1p; -<italic>m1</italic>) cells.</p><p>(C) <italic>pif1-m1</italic> (top panel) or <italic>pif1-m2</italic> cells were synchronized as in (A), and levels of nuclear or mitochondrial Pif1p or gamma-tubulin monitored by western blotting. To estimate the relative abundance of nuclear versus mitochondrial Pif1p, the amount of signal in nuclear or mitochondrial Pif1p was determined by quantitating scanned blots using Scion Image, and then this value was normalized to the amount of gamma-tubulin in the same sample. The numbers under the <italic>pif1-m1</italic> western refer to the ratio of normalized nuclear Pif1p to normalized mitochondrial Pif1p at each time point.</p><p>(D) Western blots of extracts from unbudded G1 phase cells (obtained by elutriation) and asynchronous (ASY) <italic>apc</italic>&#x00394; or APC<sup>&#x0002b;</sup> cells are shown after analysis with anti-Pif1p antibodies (top) or anti-Cbl2p antibodies (lower panel).</p></caption><graphic xlink:href="pgen.0030105.g001"/></fig><fig id="pgen-0030105-g002" position="float"><label>Figure 2</label><caption><title>Pif1p Acts on Telomerase That Is Telomere Associated in Late S/G2 Phase</title><p>DNA from the indicated strains was prepared from individual spore clones grown for ~30 generations after sporulation, digested with <italic>Xho</italic>I, separated on 1.0&#x00025; agarose gels, and analyzed by Southern blotting using a C<sub>1&#x02212;3</sub>A/TG<sub>1&#x02212;3</sub> telomeric probe. Telomere length was determined in WT (lanes 1) and <italic>pif</italic>1&#x00394; (lanes 2) cells as well as in three mutant strains in which Est2p is not telomere bound in G1 phase (<italic>tlc1</italic>&#x00394;<italic>48,</italic> lanes 4; <italic>yku80-135i,</italic> lanes 6; <italic>yku70</italic>&#x00394;<italic>,</italic> lanes 8). In each of these strains, eliminating Pif1p results in longer telomeres than in the respective single mutant (<italic>tlc1</italic>&#x00394;<italic>48 pif1</italic>&#x00394;<italic>,</italic> lanes 3; <italic>yku80-135i pif1</italic>&#x00394;<italic>,</italic> lanes 5; <italic>yku70</italic>&#x00394; <italic>pif1</italic>&#x00394;<italic>,</italic> lanes 7). For each genotype, telomere length is shown for two independent spore clones.</p></caption><graphic xlink:href="pgen.0030105.g002"/></fig><fig id="pgen-0030105-g003" position="float"><label>Figure 3</label><caption><title>Pif1p Overexpression Is Lethal in <italic>yku70</italic>&#x00394; Cells</title><p>Wild-type (WT) or <italic>yku70</italic>&#x00394; cells carried either vector alone (control) or the same vector with either WT Pif1p <italic>(GAL-PIF1)</italic> or catalytically inactive Pif1p <italic>(GAL</italic>-<italic>pif1K264A),</italic> both expressed from the galactose inducible <italic>GAL1</italic> promoter. Cells were grown overnight in 3&#x00025; raffinose synthetic medium lacking leucine. At T &#x0003d; 0, galactose was added to a final concentration of 3&#x00025; to induce protein expression. At the indicated time points, viability of the culture was monitored by plating cells onto glucose plates lacking leucine. Plates were counted after 2 d of growth at 30 &#x000b0;C.</p></caption><graphic xlink:href="pgen.0030105.g003"/></fig><fig id="pgen-0030105-g004" position="float"><label>Figure 4</label><caption><title>Pif1p Overexpression Is Lethal Only in Mutants Defective in Telomere End Protection</title><p>Strains containing the indicated plasmids (described in <xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref> legend) were grown overnight in 2&#x00025; glucose synthetic liquid medium lacking either leucine (A&#x02013;D) or leucine and tryptophan (E). Cultures were serially diluted in water and spotted onto plates containing either galactose (left) or glucose (right). Plates were photographed after 4 or 5 d (galactose) or 2 d (glucose) at 30 &#x000b0;C. (A) <italic>yku70</italic>&#x00394; and <italic>tlc1</italic>&#x00394;<italic>48</italic>; (B) <italic>yku80</italic>&#x00394; and <italic>yku80-135i</italic>; (C) WT, <italic>lig4</italic>&#x00394;, and <italic>yku70</italic>&#x00394;; (D) WT and <italic>tel1&#x00394;;</italic> (E) <italic>yku80</italic>&#x00394;, WT, <italic>yku80&#x02013;1</italic>, and <italic>yku80&#x02013;4</italic>.</p></caption><graphic xlink:href="pgen.0030105.g004"/></fig><fig id="pgen-0030105-g005" position="float"><label>Figure 5</label><caption><title>Overexpression of Pif1p Decreases Viability of <italic>cdc13&#x02013;1</italic> Cells at Otherwise Permissive Temperatures</title><p>Wild-type or <italic>cdc13&#x02013;1</italic> strains containing the indicated plasmid (as described in <xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref> legend) were grown overnight at 23 &#x000b0;C in synthetic liquid glucose medium lacking leucine. Cultures were serially diluted in water, spotted onto plates lacking leucine and containing either galactose (left) or glucose (right), and incubated at 23 &#x000b0;C for 7 d (galactose) or 5 d (glucose).</p></caption><graphic xlink:href="pgen.0030105.g005"/></fig><fig id="pgen-0030105-g006" position="float"><label>Figure 6</label><caption><title>Deleting <italic>EXO1</italic> Reduces Lethality Caused by Pif1p Overexpression in <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> Cells</title><p>Tetratype tetrads derived from diploids heterozygous for both <italic>exo1</italic>&#x00394; and <italic>yku70</italic>&#x00394; (A) or <italic>exo1</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> (B) and containing the indicated plasmids (as described in <xref ref-type="fig" rid="pgen-0030105-g003">Figure 3</xref> legend) were grown overnight in selective liquid media containing glucose at 30 &#x000b0;C (A) or 23 &#x000b0;C (B). Cultures were serially diluted in water and spotted onto selective galactose (left) or glucose (right) plates and incubated at 30 &#x000b0;C for 5 d (galactose) or 2 d (glucose &#x0005b;A&#x0005d;) or at 23 &#x000b0;C for 7 d (galactose) or 5 d (glucose &#x0005b;B&#x0005d;).</p></caption><graphic xlink:href="pgen.0030105.g006"/></fig><fig id="pgen-0030105-g007" position="float"><label>Figure 7</label><caption><title>Deletion of Nuclear Pif1p Suppresses the Temperature Sensitive Growth of <italic>yku70</italic>&#x00394; and <italic>cdc13&#x02013;1</italic> Cells</title><p>Tetratype tetrads were derived from diploids heterozygous for both <italic>pif1-m2</italic> (these cells express only the mitochondrial form of Pif1p) and <italic>yku70</italic>&#x00394; (A) or both <italic>pif1-m2</italic> and <italic>cdc13&#x02013;1</italic> (B). Cells were grown in complete liquid media overnight at 23 &#x000b0;C, then serially diluted in water, spotted onto YEPD plates, and incubated at the indicated temperatures for two days, except for the cells grown at 23 &#x000b0;C, which were incubated for three days.</p></caption><graphic xlink:href="pgen.0030105.g007"/></fig><fig id="pgen-0030105-g008" position="float"><label>Figure 8</label><caption><title>Disruption of the Ku-Telomerase RNA Interaction Exacerbates the Temperature Sensitive Growth of <italic>cdc13&#x02013;1</italic> Strains</title><p>Spore clones of the indicated genotypes from tetrads derived from diploids heterozygous for both <italic>cdc13&#x02013;1</italic> and <italic>tlc1</italic>&#x00394;<italic>48</italic> (A) or <italic>cdc13&#x02013;1 and yku80-135i</italic> (B) were grown in complete liquid media for 2 d at 20 &#x000b0;C then serially diluted in water, spotted onto YEPD plates, and incubated at the indicated temperatures for 2 d (26.8 &#x000b0;C and 28.2 &#x000b0;C) or 3 d (23 &#x000b0;C and 26.8 &#x000b0;C).</p></caption><graphic xlink:href="pgen.0030105.g008"/></fig><table-wrap id="pgen-0030105-t001" content-type="1col" position="float"><label>Table 1</label><caption><p>Primers Used for Deletion of <italic>EXO1</italic> and <italic>YKU80</italic></p></caption><graphic xlink:href="pgen.0030105.t001"/></table-wrap></sec><fn-group><fn id="n104" fn-type="present-address"><p>&#x000a4; Current address: School of Natural Health and Sciences, Barry University, Miami Shores, Florida, United States of America</p></fn><fn id="ack1" fn-type="con"><p><bold>Author contributions.</bold> LRV conceived of testing the effects of Pif1p overexpression on viability of <italic>yku</italic> and <italic>cdc13&#x02013;1</italic> cells. LRV, JAP, and VAZ conceived, designed, and analyzed the experiments (except for the experiments in <xref ref-type="fig" rid="pgen-0030105-g001">Figures 1</xref>D and <xref ref-type="supplementary-material" rid="pgen-0030105-sg001">S1</xref>) and wrote the paper. LRV, JAP, BRT, JAB, and MTO performed the experiments. BRT, JAB, and DPT designed, conducted, and analyzed the experiments presented in <xref ref-type="fig" rid="pgen-0030105-g001">Figures 1</xref>D and <xref ref-type="supplementary-material" rid="pgen-0030105-sg001">S1</xref>.</p></fn><fn id="ack2" fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grants to VAZ (R37 GM026938 and RO1 GM43265) and DPT (RO1 GM070539) from the National Institutes of Health (NIH). LRV was supported in part by a Helen Hay Whitney postdoctoral fellowship, by RO1 GM43265, and in part by Barry University School of Natural and Health Sciences Research Scholarship Funds. JAP was supported in part by an NIH training grant (5T32 CA009528) and in part by a New Jersey Commission on Cancer Research fellowship (07&#x02013;1062-CCR-EO); and JAB was supported in part by a Damon Runyon Cancer Research Foundation postdoctoral fellowship.</p></fn><fn id="ack3" fn-type="conflict"><p><bold>Competing interests.</bold> The authors have declared that no competing interests exist.</p></fn></fn-group></back></article> 